Cocoromil Launches Innovative Home Heart Monitoring in Yamanashi Prefecture

Cocoromil's Innovative Heart Monitoring Initiative in Yamanashi

Cocoromil, headquartered in Shinjuku, Tokyo, has recently been approved for participation in Yamanashi Prefecture's "9th Phase TRY! YAMANASHI! Demonstration Experiment Support Project." This initiative aims to utilize the company’s pioneering home ECG monitoring service, the "Home Heart Dock Pro," to enhance the early detection of heart diseases, prolong healthy lifespans, and promote seamless collaboration with local medical institutions.

Background of Project Adoption

Yamanashi Prefecture faces a significant challenge, as heart disease ranks first among the illnesses that lead to care certification. This critical public health issue is compounded by high rates of strokes, which exceed the national average mortality rate. Conversely, the area is also recognized for its high life expectancy, ranking third for males and fourth for females in Japan. The local population exhibits a strong awareness of health, making it an ideal location for implementing Cocoromil's "Home Heart Dock®" service. This technology aims to identify arrhythmias, sleep apnea, and early signs of stress that are often overlooked in traditional quick tests, thereby preventing unforeseen cardiac events and dependency on caregiving.

For more on the support project, visit the official website: 9th Phase TRY! YAMANASHI!

Key Components of the Demonstration Project

1. Monitoring Provision: The Home Heart Dock Pro will be offered to up to 100 employees of local companies in Yamanashi Prefecture.
2. Online Clinic Integration: If any abnormalities are detected, Cocoromil will cover the costs for consultation through an online clinic and issue referrals to local hospitals as necessary.
3. Assessment Metrics: The project will evaluate:
- Detection rates of potential heart diseases
- Correlation between sleep quality and stress
- Behavioral change rates regarding health and medical consultation
- Connectivity to local healthcare providers

Significance and Expected Impact of Implementation in Yamanashi

1. Data-Driven Local Response: Given the high prevalence of heart disease and the rising mortality rate from cerebrovascular disease, proactive cardiovascular strategies could play a crucial role in extending healthy lifespans.
2. Reduction in Medical and Care Expenditures: Early detection of conditions like arrhythmias (specifically atrial fibrillation) could potentially save about 8 million yen per person in healthcare and caregiving costs.
3. Sustaining Workforce: By mitigating risks of sudden death, loss of mobility, and caregiving discontinuity, the initiative supports local employment stability.

Cocoromil's Innovative Services and Technologies

1. Revolutionary Long-Term Monitoring: The Home Heart Dock provides long-term ECG monitoring using wearable devices, detecting arrhythmias and sleep quality issues for durations of 9 to 24 hours, vastly improving data visibility compared to the traditional 30-second tests.
2. Enhanced Monitoring Model: The new model used in this demonstration features six-axis sensors for comprehensive tracking of movements and breathing, significantly improving the detection accuracy of sleep quality and sleep apnea.
3. User-Centric Design: The service emphasizes accessibility, demonstrated by the oldest user being 93 years old.
4. Streamlined Health Pathway: Cocoromil’s process offers comprehensive support that encompasses testing, diagnosis, and referrals to local medical facilities, promoting actionable health behavior changes (with a conversion rate of 80% based on previous company surveys).

CEO Daiki Hayashi's Comments

"Having lost my mother unexpectedly, I have made it my mission to reduce the number of people who suffer from illnesses due to lack of awareness. Through this demonstration in Yamanashi, we aim to establish a new standard for home-based long-term ECG monitoring and medical collaboration, expanding it from our community to the nation."

Company Overview

Cocoromil aims to eliminate sudden deaths worldwide, ensuring a society where no one has to regret falling ill. Their services, including the acclaimed Home Heart Dock®, allow individuals to easily monitor their heart health from home, ushering in a new standard in preventive healthcare. Led by Daiki Hayashi, Cocoromil is situated at 2F, Kanno Building, 6-2-16, Nishi-Shinjuku, Shinjuku-ku, Tokyo, and was established in November 2021, focusing on health and clinical research.

Key Details:

- CEO: Daiki Hayashi
- Location: 2F, Kanno Building, 6-2-16, Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023
- Established: November 2021
- Business Activities: Healthcare and Clinical Research
- Service Offerings: Home heart monitoring, arrhythmia detection, stress assessment, and more
- Major Certifications: Medical device manufacturing and sales accreditation
- Website: Cocoromil Official Site